Meizhu Wu
-
- Cancer, Hypoxia, and Metabolism 3
-
- Metabolomics and Mass Spectrometry Studies 5
- RNA modifications and cancer 4
- Phytochemical Studies and Bioactivities 3
-
- Biological and pharmacological studies of plants 4
-
- Cardiac Fibrosis and Remodeling 4
-
- Chromatography in Natural Products 3
-
- Computational Drug Discovery Methods 3
- Journals
- Biomedicine & Pharmacotherapy (6 papers)European Journal of Pharmacology (3 papers)Frontiers in Pharmacology (3 papers)
- Partner nations
- ChinaUnited StatesMalaysia
In The Last Decade
Meizhu Wu
40 papers receiving 448 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 72
- Molecular Biology 268
- Complementary and alternative medicine 32
- Pharmacology 63
- Cardiology and Cardiovascular Medicine 81
Countries citing papers authored by Meizhu Wu
This map shows the geographic impact of Meizhu Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meizhu Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meizhu Wu more than expected).
Fields of papers citing papers by Meizhu Wu
This network shows the impact of papers produced by Meizhu Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meizhu Wu. The network helps show where Meizhu Wu may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Meizhu Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 1 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 9 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 6 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 12 | |
| 10 | 2023 | 1 | |
| 11 | 2022 | 13 | |
| 12 | 2022 | 10 | |
| 13 | 2021 | 5 | |
| 14 | 2021 | 26 | |
| 15 | 2021 | 25 | |
| 16 | 2020 | 15 | |
| 17 | 2020 | 8 | |
| 18 | 2020 | 18 | |
| 19 | 2019 | 56 | |
| 20 | 2012 | 17 |
About Meizhu Wu
Meizhu Wu is a scholar working on Pharmacology, Biochemistry and Cardiology and Cardiovascular Medicine, having authored 43 papers that have together received 452 indexed citations. Recurring topics across this work include Metabolomics and Mass Spectrometry Studies (5 papers), Biological and pharmacological studies of plants (4 papers), RNA modifications and cancer (4 papers), Cardiac Fibrosis and Remodeling (4 papers), Chromatography in Natural Products (3 papers), Phytochemical Studies and Bioactivities (3 papers), Cancer, Hypoxia, and Metabolism (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Cancer Research (72 citations), Molecular Biology (268 citations) and Complementary and alternative medicine (32 citations). Meizhu Wu has collaborated with scholars based in China, United States and Malaysia. Frequent co-authors include Aling Shen, Youqin Chen, Zhiqing Shen, Jun Peng, Liya Liu, Ying Cheng, Xiangyan Wu, Jianfeng Chu, Jun Peng and Xiaoying Lin. Their work appears in journals such as Biomedicine & Pharmacotherapy, European Journal of Pharmacology, Frontiers in Pharmacology, Scientific Reports and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.